209 related articles for article (PubMed ID: 18055394)
41. Summaries for patients. Is obesity harmful if metabolic factors are normal?
Ann Intern Med; 2013 Dec; 159(11):I-26. PubMed ID: 24297208
[No Abstract] [Full Text] [Related]
42. Insulin and IGFs in obesity-related breast cancer.
Belardi V; Gallagher EJ; Novosyadlyy R; LeRoith D
J Mammary Gland Biol Neoplasia; 2013 Dec; 18(3-4):277-89. PubMed ID: 24154546
[TBL] [Abstract][Full Text] [Related]
43. Associations of acute-phase reactants with metabolic syndrome in middle-aged overweight or obese people.
Vallianou NG; Evangelopoulos AA; Panagiotakos DB; Georgiou AT; Zacharias GA; Vogiatzakis ED; Avgerinos PC
Med Sci Monit; 2010 Feb; 16(2):CR56-60. PubMed ID: 20110915
[TBL] [Abstract][Full Text] [Related]
44. Insulin-resistance and benign prostatic hyperplasia: the connection.
Vikram A; Jena G; Ramarao P
Eur J Pharmacol; 2010 Sep; 641(2-3):75-81. PubMed ID: 20553919
[TBL] [Abstract][Full Text] [Related]
45. Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review.
Biadgo B; Abebe M
Korean J Gastroenterol; 2016 Apr; 67(4):168-77. PubMed ID: 27112242
[TBL] [Abstract][Full Text] [Related]
46. [Prevalence of obesity and cardiovascular risk factors in a group of paediatric patients with type 1 diabetes].
Palomo Atance E; Giralt Muiña P; Ballester Herrera MJ; Ruiz Cano R; León Martín A; Giralt Muiña J
An Pediatr (Barc); 2013 Jun; 78(6):382-8. PubMed ID: 23273627
[TBL] [Abstract][Full Text] [Related]
47. Metabolic syndrome: is it a syndrome? Does it matter?
Kahn R
Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
[No Abstract] [Full Text] [Related]
48. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study.
Kang HW; Kim D; Kim HJ; Kim CH; Kim YS; Park MJ; Kim JS; Cho SH; Sung MW; Jung HC; Lee HS; Song IS
Am J Gastroenterol; 2010 Jan; 105(1):178-87. PubMed ID: 19755965
[TBL] [Abstract][Full Text] [Related]
49. Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients.
Chang CK; Ulrich CM
Diabetologia; 2003 May; 46(5):595-607. PubMed ID: 12764580
[TBL] [Abstract][Full Text] [Related]
50. The metabolic syndrome--from insulin resistance to obesity and diabetes.
Gallagher EJ; Leroith D; Karnieli E
Med Clin North Am; 2011 Sep; 95(5):855-73. PubMed ID: 21855696
[TBL] [Abstract][Full Text] [Related]
51. Is obesity an adaptative response to inflammation?
Ailhaud G
Obes Rev; 2012 May; 13(5):480-1. PubMed ID: 22500727
[No Abstract] [Full Text] [Related]
52. [Insulin resistance and other expressions of metabolic syndrome in obese Chilean children].
Barja S; Arteaga A; Acosta AM; Hodgson MI
Rev Med Chil; 2003 Mar; 131(3):259-68. PubMed ID: 12790074
[TBL] [Abstract][Full Text] [Related]
53. [Pathophysiological characterization of metabolic syndrome in overweight, obese and type 2 diabetic Algerian subjects: interest of adipokines as dysmetabolic biomarkers].
Benbaibeche H; Haffaf el M; Kacimi G; Oudjit B; Koceir E
Ann Biol Clin (Paris); 2014; 72(4):463-72. PubMed ID: 25119805
[TBL] [Abstract][Full Text] [Related]
54. A weighty problem: metabolic perturbations and the obesity-cancer link.
O'Flanagan CH; Bowers LW; Hursting SD
Horm Mol Biol Clin Investig; 2015 Aug; 23(2):47-57. PubMed ID: 26167982
[TBL] [Abstract][Full Text] [Related]
55. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review.
Giovannucci E
Am J Clin Nutr; 2007 Sep; 86(3):s836-42. PubMed ID: 18265477
[TBL] [Abstract][Full Text] [Related]
56. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
[TBL] [Abstract][Full Text] [Related]
57. [The hyperinsulinic syndrome with diabetes mellitus in the development of human obesity].
Eşanu C; Klepsch I; Mitrache L; Juvina E
Stud Cercet Endocrinol; 1973; 24(5):373-85. PubMed ID: 4745107
[No Abstract] [Full Text] [Related]
58. All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies.
Karmali R; Dalovisio A; Borgia JA; Venugopal P; Kim BW; Grant-Szymanski K; Hari P; Lazarus H
Blood Rev; 2015 Mar; 29(2):71-80. PubMed ID: 25433571
[TBL] [Abstract][Full Text] [Related]
59. Obesity related hyperinsulinaemia and hyperglycaemia and cancer development.
Becker S; Dossus L; Kaaks R
Arch Physiol Biochem; 2009 May; 115(2):86-96. PubMed ID: 19485704
[TBL] [Abstract][Full Text] [Related]
60. [Metabolic syndrome: more questions than answers].
Chibisov SM; Rapoport SI; Kolesnikov DB; Loboda AIu
Klin Med (Mosk); 2008; 86(6):30-5. PubMed ID: 18720708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
